Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 8 of 8 publications.

Bai S, Tornello SL, Mogle JA, Feinberg ME. Daily implementation of health-protective behaviors and family life during the early months of the COVID-19 pandemic. Fam Process. 2024 Mar;63(1):428-42. doi: 10.1111/famp.12870.

Le Y, Mogle JA, Feinberg ME. Trajectories of parent and child well-being across the pandemic year: role of financial strain, social distancing, and COVID-19 prevalence. Fam Process. 2023 Sep;62(3):1134-46. doi: 10.1111/famp.12823

Feinberg ME, Gedaly L, Mogle J, Hostetler ML, Cifelli JA, Tornello SL, Lee JK, Jones DE. Building long-term family resilience through universal prevention: 10-year parent and child outcomes during the COVID-19 pandemic. Fam Process. 2022 Mar;61(1):76-90. doi: 10.1111/famp.12730

Jenkins AIC, Fredman SJ, Le Y, Mogle JA, McHale SM. Religious coping and gender moderate trajectories of marital love among black couples. Fam Process. 2022 Mar;61(1):312-25. doi: 10.1111/famp.12645

Herring WL, Herrmann JW. The single-day surgery scheduling problem: sequential decision-making and threshold-based heuristics. OR spectrum: quantitative approaches in management. 2012 Apr 1;34(2):429-59.

Walker EA, Picker MJ, Granger AL, Dykstra LA. Effects of opioids in morphine-treated pigeons trained to discriminate among morphine, the low-efficacy agonist nalbuphine, and saline. J Pharmacol Exp Ther. 2004 Jul;310(1):150-8.

Allen RM, Granger AL, Dykstra LA. The competitive N-methyl-D-aspartate receptor antagonist (-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid (LY235959) potentiates the antinociceptive effects of opioids that vary in efficacy at the mu-opioid receptor. J Pharmacol Exp Ther. 2003 Nov 1;307(2):785-92.

Allen RM, Granger AL, Dykstra LA. Dextromethorphan potentiates the antinociceptive effects of morphine and the delta-opioid agonist SNC80 in squirrel monkeys. J Pharmacol Exp Ther. 2002 Feb 1;300(2):435-41.